About

Journal of Molecular Medicine and Pharmaceutical Innovations is a peer-reviewed scientific journal dedicated to promoting research and knowledge exchange in molecular medicine, pharmaceutical sciences, and biomedical innovation. Published biannually, the journal aims to provide a platform for scientists, healthcare professionals, pharmacists, and academicians to communicate significant findings that contribute to advancements in disease understanding, drug development, and therapeutic practices.

The journal encourages interdisciplinary research that bridges molecular biology, pharmacology, pharmaceutical technology, and clinical medicine. It welcomes scholarly contributions exploring the molecular basis of diseases, innovative drug discovery approaches, advanced drug delivery systems, and emerging therapeutic strategies.

Aims and Scope

The journal seeks to disseminate high-quality scientific research in the following areas:

  • Molecular and Cellular Medicine: Molecular pathways, cellular mechanisms, genetic regulation, disease biomarkers, and molecular diagnostics.

  • Pharmaceutical Research and Development: Drug formulation, pharmaceutical technology, novel dosage forms, and drug delivery systems.

  • Drug Discovery and Therapeutics: Identification of therapeutic targets, drug screening, preclinical research, and development of innovative medicines.

  • Pharmacology and Toxicology: Pharmacological mechanisms, drug interactions, pharmacokinetics, pharmacodynamics, and drug safety.

  • Clinical and Translational Medicine: Clinical investigations, translational research, and the application of laboratory discoveries to patient care.

  • Biotechnology and Molecular Therapeutics: Biopharmaceutical development, biological therapies, molecular targeting, and emerging biomedical technologies.

  • Disease Mechanisms and Treatment: Research on cancer, infectious diseases, cardiovascular disorders, metabolic diseases, neurological conditions, and other health challenges.

  • Emerging Pharmaceutical Innovations: Personalized medicine, precision therapeutics, nanomedicine, and novel approaches to treatment development.